Paper767197
The current status of alpha-1-antityrpsin, a protease inhibitor, in gastrointestinal disease.
Sharp HL. Gastroenterology, 1976. Cited by 121 papers, by iCite.
Cite this record
ConductScience Library. The current status of alpha-1-antityrpsin, a protease inhibitor, in gastrointestinal disease. Papers, record 767197. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/767197
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The current status of alpha-1-antityrpsin, a protease inhibitor, in gastrointestinal disease.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Diseases | Major topic |
| Liver Diseases | Major topic |
| Liver Neoplasms | Major topic |
| Pulmonary Emphysema | Major topic |
| alpha 1-Antitrypsin Deficiency | Major topic |
| Adult | |
| Alleles | |
| Humans | |
| Infant | |
| Infant, Newborn | |
| Liver | |
| alpha 1-Antitrypsin |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40440324 | Transitory impact of subclinical Shigella infections on biomarkers of environmental enteropathy in children under 2 years. | PLoS Negl Trop Dis | 2025 | https://conductscience.org/library/papers/40440324 | PubMed |
| 29032169 | Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency. | Mol Ther | 2017 | https://conductscience.org/library/papers/29032169 | PubMed |
| 26819512 | Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26819512 | PubMed |
| 25595554 | Methods to determine intestinal permeability and bacterial translocation during liver disease. | J Immunol Methods | 2015 | https://conductscience.org/library/papers/25595554 | PubMed |
| 23308132 | Pathogen induced changes in the protein profile of human tears from Fusarium keratitis patients. | PLoS One | 2013 | https://conductscience.org/library/papers/23308132 | PubMed |
| 23185075 | Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. | Am J Trop Med Hyg | 2013 | https://conductscience.org/library/papers/23185075 | PubMed |
| 14712302 | Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. | Gene Ther | 2004 | https://conductscience.org/library/papers/14712302 | PubMed |
| 6985708 | Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. | N Engl J Med | 1980 | https://conductscience.org/library/papers/6985708 | PubMed |
| 6976926 | PiMheerlen, alpha PiM allele resulting in very low alpha 1-antitrypsin serum levels. | Hum Genet | 1981 | https://conductscience.org/library/papers/6976926 | PubMed |
| 6969773 | Limited proteolysis by macrophage elastase inactivates human alpha 1-proteinase inhibitor. | J Exp Med | 1980 | https://conductscience.org/library/papers/6969773 | PubMed |
| 6794707 | Alpha 1-antitrypsin deficiency and liver disease. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6794707 | PubMed |
| 6326791 | Alpha 1-antitrypsin levels and phenotypes and hepatitis B serology in liver cancer. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6326791 | PubMed |
| 6207081 | Lymphocyte cytotoxicity to autologous hepatocytes in alpha 1-antitrypsin deficiency. | Gut | 1984 | https://conductscience.org/library/papers/6207081 | PubMed |
| 6135912 | Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt. | Lancet | 1983 | https://conductscience.org/library/papers/6135912 | PubMed |
| 3872632 | Reference ranges for serum alpha 1 antitrypsin. | Arch Dis Child | 1985 | https://conductscience.org/library/papers/3872632 | PubMed |
| 3500042 | The human alpha 1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes. | EMBO J | 1987 | https://conductscience.org/library/papers/3500042 | PubMed |
| 2840112 | Alpha 1-antitrypsin and serum albumin in tear fluids in acute adenovirus conjunctivitis. | Br J Ophthalmol | 1988 | https://conductscience.org/library/papers/2840112 | PubMed |
| 2167827 | Ascitic fluid alpha 1-antitrypsin. | Dig Dis Sci | 1990 | https://conductscience.org/library/papers/2167827 | PubMed |
| 871797 | Are liver function tests outmoded? | Br Med J | 1977 | https://conductscience.org/library/papers/871797 | PubMed |
| 649765 | The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. | J Clin Pathol | 1978 | https://conductscience.org/library/papers/649765 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SERPINA1 | 5265 | PubTator's text mining | https://conductscience.org/library/genes/5265 | NCBI Gene |
| SERPINA13P | 388007 | PubTator's text mining | https://conductscience.org/library/genes/388007 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/767197
GET https://conductscience.org/api/papers/v1/767197/cited_by?page=2